Kusuri No Aoki Holdings Co., Ltd.
Notice of Agenda for the Annual General Meeting of Shareholders | August 19, 2026
Aoki Drug Holdings, Inc. announced that it has resolved to propose the appointment of 11 directors and 1 substitute statutory auditor as agenda items at the 28th Annual General Meeting of Shareholders scheduled for August 19, 2026.
Key Figures
- Agenda proposal: Appointment of 11 directors
- Substitute statutory auditor: 1 appointment
- Meeting date: August 19, 2026
AI要約
Overview of Agenda Items
Aoki Drug Holdings, Inc. has resolved to submit proposals for the appointment of 11 directors and 1 substitute statutory auditor at the Annual General Meeting of Shareholders scheduled for August 19, 2026. Details are provided in related materials dated July 16, 2026.
Impact on Shareholders and Future Plans
This agenda pertains to management personnel changes and aims to stabilize the management structure through shareholder voting. Details of the proposals and candidate information have been separately disclosed, and shareholders may participate either by attending the meeting or exercising voting rights.
Aoki Drug Holdings, Inc.
Company overview · Stock price · Financial data · All IR
